DOCSLIB.ORG

Vaccine Orders List

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Vaccine Orders List Provider Name/Clinic Name County Pfizer Doses Requested Total Allocated Pfizer Moderna Doses Requested Total Allocated Moderna Janssen Doses Requested Total Allocated Janssen 03 Appling Appling 0 0 0 0 0 0 Apex Pharmacy Appling 0 0 100 140 0 0 Appling County Health Department Appling 0 0 11000 6900 0 100 Appling Healthcare Systems Appling 10920 5460 2700 2300 0 0 Baxley Wellness Pharmacy Appling 0 0 2600 1940 0 0 Carroll Co Primary Hlth Care Clinic Appling 0 0 100 100 0 0 Comprehensive Primary Care Appling 3510 0 0 0 0 0 Cvs 0962 Appling 0 0 0 0 0 0 Cvs 2470 Appling 0 0 0 0 0 0 Cvs 4160 Appling 0 0 0 0 0 0 Cvs 4719 Appling 0 0 0 0 0 0 Cvs 6861 Appling 0 0 0 0 0 0 Rn D Llc Appling 0 0 0 0 0 0 Walmart Store 5392 Appling 0 0 0 0 0 0 Weaveranderson Medical Center Appling 0 0 0 0 0 0 Wheeler Correctional Facility Appling 0 0 0 0 0 0 Atkinson Co Health Department Atkinson 0 0 2000 2700 0 100 South Central Family Medicine Pearson Atkinson 0 0 1500 2100 0 300 Bacon County Health Department Bacon 0 0 1700 2600 0 300 Bacon County Hospital And Health System Bacon 0 0 900 1400 0 0 Carver Drug Company Bacon 975 0 1100 1200 0 0 Fresenius Kidney Care Alma Bacon 0 0 0 0 0 0 Lamars Pharmacy Bacon 0 0 700 700 0 0 Walgreens 18095 Bacon 0 0 0 0 0 0 Baker County Health Department Baker 0 0 2100 3000 0 0 Baldwin County Health Department Baldwin 0 0 7400 8300 0 400 Bostick Nursing Center Baldwin 0 0 0 200 0 0 Central State Hospital Baldwin 0 0 1500 1000 0 0 Community Health Care System Inc Baldwi Baldwin 0 0 300 700 0 0 Dialysis Center Of Milledgeville Baldwin 0 0 200 100 0 0 Georgia College State Baldwin 0 0 1800 2100 0 400 Georgia War Veterans Home Baldwin 0 0 400 200 0 0 Hm Drugs Baldwin 0 0 1600 200 0 0 Kroger Pharmacy 01100694 Baldwin 0 0 1300 400 0 0 Medical Arts Pharmacy Baldwin 0 0 2500 1400 0 0 Middle Georgia Correctional Complex Pharmacy Baldwin 0 0 6900 46300 0 1000 Patient First Medical Ctr Inc Baldwin 0 0 0 0 0 0 Pediatrics R Us Baldwin 0 0 0 0 0 0 Walgreens 10832 Baldwin 0 0 0 0 0 0 Walmart 1121 Baldwin 0 0 0 0 0 0 Banks County Health Department Banks 5850 7020 17900 9500 0 200 Homer Drugs Llc Banks 975 0 3000 3100 0 2500 Meadows Surgical Arts Inc Banks 0 0 0 0 0 0 Medlink Georgia - Banks Banks 0 0 700 1300 0 0 Walmart Store 3 Banks 0 0 0 0 0 0 Braselton Pharmacy Barrow 0 0 1000 1000 0 0 Farmer'S Prescription Shop Barrow 0 0 1600 1600 0 0 Harrison Poultry Wellness Center Barrow 0 0 200 0 0 300 Health Associates Of Georgia, Inc. Barrow 4290 4485 7000 4600 0 0 Ingles Pharmacy #451 Barrow 0 0 1900 2800 0 0 Ingles Pharmacy #57 Barrow 0 0 1900 2600 0 0 Ivydale Wellness Center Llc Barrow 4485 3510 900 600 0 0 Medlink Georgia Winder Barrow 0 0 600 1500 0 0 Ngpg Auburn Primary Care Barrow 0 0 1100 1100 0 0 Ngpg Family Health Associates Barrow 0 0 1200 700 0 0 Ngpg Gateway Exchange Barrow 0 0 200 200 0 0 Publix Pharmacy#0108 Barrow 0 0 1500 900 0 0 Publix Pharmacy#0480 Barrow 0 0 2200 1800 0 0 Publix Pharmacy#1251 Barrow 0 0 1700 1200 0 0 Walgreens 12726 Barrow 0 1170 0 0 0 0 Walmart Store 520 Barrow 0 0 0 0 0 0 Provider Name/Clinic Name County Pfizer Doses Requested Total Allocated Pfizer Moderna Doses Requested Total Allocated Moderna Janssen Doses Requested Total Allocated Janssen Winder Health Care And Rehab Barrow 0 0 300 100 0 0 Adairsville Drug Bartow 1170 1170 3000 1400 0 0 Bartow County Fire And Emergency Service Bartow 5850 4680 300 300 0 300 Bartow County Fire And Emergency Service Bartow 0 0 0 0 0 0 Bartow County Fire And Emergency Service Bartow 0 0 0 0 0 0 Bartow County Fire And Emergency Service Bartow 0 0 0 0 0 0 Bartow County Health Department Bartow 0 0 35900 19400 0 500 Bartow Family Health Center Bartow 0 0 800 1000 0 100 Caring Partners Medical Group Bartow 1170 0 200 200 0 0 Cartersville Medical Center Bartow 0 0 2700 2700 0 0 Center For Infectious Diseases Bartow 0 0 0 0 0 0 Family Care Of Cartersville Bartow 0 0 1300 1400 0 0 Floyd Primary Care Bartow 0 0 0 0 0 0 Fords Pharmacy Llc Bartow 0 0 1200 1200 0 0 Hamilton Ems Bartow 0 0 400 500 0 0 Highlands Senior Living Bartow 0 0 0 0 0 0 Ingles Pharmacy #483 Bartow 0 0 1900 2600 0 0 Ingles Pharmacy #76 Bartow 0 0 1800 2600 0 0 Kroger Pharmacy 01100629 Bartow 0 0 1400 500 0 0 Mvc Bartow Bartow 0 62010 0 0 0 500 Publix Pharmacy#0554 Bartow 0 0 1500 1200 0 0 The Family Medicine Clinic Bartow 0 0 500 700 0 0 Urgent Care Cartersville Bartow 0 0 0 0 0 0 Walgreens 15180 Bartow 0 1170 0 0 0 0 Walgreens 17686 Bartow 0 0 0 0 0 0 Walmart Health 615 Bartow 0 0 0 0 0 0 Walmart Store 615 Bartow 0 0 0 0 0 0 West End Pharmacy Bartow 4680 2340 8400 7600 0 2900 Ben Hill County Health Department Ben Hill 0 0 4000 4900 0 600 Dorminy Medical Center Ben Hill 0 0 4200 4500 0 0 Kids Healthfitzgerald Ben Hill 0 0 0 0 0 0 Mainstreet Family Care Fitzgerald Ben Hill 0 0 1000 0 0 0 Pruitthealth Fitzgerald Ben Hill 0 0 0 0 0 0 Walgreens 19147 Ben Hill 0 0 0 0 0 0 Walmart Store 686 Ben Hill 0 0 0 0 0 0 Berrien County Health Dept Berrien 0 0 2800 3600 0 100 Berrien County Hospital Berrien 0 1170 200 200 0 0 Betty Dupree Healthcare Center Berrien 0 0 1500 1800 0 0 Dogwood Pharmacy Berrien 0 0 0 0 0 0 Walgreens 18291 Berrien 0 0 0 0 0 0 Aramacon Dialysis Center Llc Bibb 0 0 0 0 0 0 Burton Medical Group Bibb 0 0 0 0 0 0 Centeral Georgia Internal Med Bibb 0 0 0 0 0 700 Childrens Health Center Bibb 0 0 0 0 0 0 Coliseum Medical Center Bibb 975 0 2600 2900 0 0 Coliseum Ped Adol Care Inc Bibb 0 0 0 0 0 0 Community Health Care Systems Inc Bibb 0 0 0 0 0 0 Cvs 2472 Bibb 0 0 0 0 0 0 Dialysis Center Of Macon Bibb 0 0 100 100 0 0 East Macon Dialysis Center Bibb 0 0 100 200 0 0 Eastview Nursing Center Bibb 0 0 0 0 0 0 Family Care Of Middle Georgia(Formerly Macon Pediatrics) Bibb 0 0 3200 3000 0 0 Feet First Podiatry Llc Bibb 0 0 0 0 0 0 First Choice Primary Care Bibb 0 0 2400 3000 0 0 Georgia Arrhythmia Consultants And Resea Bibb 0 0 400 500 0 0 Harry A Linkous Md Bibb 0 0 0 0 0 0 Internal Medicine Associates, Pc Bibb 0 0 1600 1100 0 0 Iv Care Options Bibb 0 0 400 400 0 0 Kroger Pharmacy 01100328 Bibb 0 0 1300 400 0 0 Kroger Pharmacy 01100355 Bibb 0 0 1300 400 0 0 Kroger Pharmacy 01100378 Bibb 0 0 1200 300 0 0 Provider Name/Clinic Name County Pfizer Doses Requested Total Allocated Pfizer Moderna Doses Requested Total Allocated Moderna Janssen Doses Requested Total Allocated Janssen Kroger Pharmacy 01100400 Bibb 0 0 1400 700 0 0 Kroger Pharmacy 01100411 Bibb 0 0 1300 200 0 0 Kroger Pharmacy 01100425 Bibb 0 0 1300 300 0 0 Macon-Bibb County Health Dept Bibb 0 0 19800 13000 0 400 Macon Pharmacy Bibb 0 0 0 0 0 0 Macon Southside Dialysis Center Bibb 0 0 1000 600 0 0 Mercer University Student Health Center Bibb 2340 4680 1000 1000 0 0 Mga Health Clinicmiddle Ga State Univer Bibb 0 0 400 500 0 0 Middle Georgia Heart Vascular Llc Bibb 0 0 0 0 0 0 Mvc Bibb Bibb 0 58050 0 100 0 200 Navicent Health Bibb 78195 54000 66600 13050 0 0 Nchd District Office Bibb 0 0 15000 1700 0 1700 Nightingale Infusion Bibb 6435 1950 700 200 0 0 Nurse Care Management Solutions Bibb 0 0 0 0 0 0 Orthogeorgia Bibb 0 0 0 0 0 0 Piedmont Orthopedics Bibb 0 0 1500 500 0 0 Powells Bloomfield Pharmacy Bibb 0 0 200 300 0 0 Primary Pediatrics Pc Bibb 2070 570 0 0 0 0 Pruitthealth Macon Bibb 1170 1170 300 280 0 300 Pruitthealthpeake Bibb 1620 0 0 0 0 0 Publix Pharmacy #1700 Bibb 0 0 2000 1400 0 0 Publix Pharmacy#1263 Bibb 0 0 1800 1500 0 0 Regency Hospital Company Of Macon, Llc Bibb 0 0 600 600 0 0 Renal Physicians Of Ga Bibb 0 0 900 1000 0 0 Sams Club Store 8225 Bibb 0 0 0 0 0 0 Scotts Pharmacy Bibb 0 0 900 1300 0 0 Southern Primary Care Bibb 0 0 1400 600 0 0 Tlc Of Georgia Llc The Little Clinic Har Bibb 0 0 0 0 0 0 Top Dog Operations Bibb 15210 5850 7600 2100 0 0 U Save It Pharmacy - Macon Bibb 0 0 1800 1400 0 0 Walgreens #10634 Bibb 0 0 800 0 0 0 Walgreens 7229 Bibb 0 0 0 0 0 0 Walmart 1076 Bibb 0 0 0 0 0 0 Walmart 1153 Bibb 0 0 0 0 0 0 Walmart Health 1153 Bibb 0 0 0 0 0 0 Walmart Store 2890 Bibb 0 0 0 0 0 0 Wesleyan College Bibb 975 0 1700 1100 0 0 Your Corner Drug Store Llc Bibb 0 0 1000 1500 0 0 Your Doctors Immediate Care Bibb 0 0 400 400 0 0 Bleckley County Health Dept Bleckley 0 0 4000 4500 0 0 Bleckley Memorial Hospital Bleckley 0 0 600 1600 0 0 Middle Georgia College Bleckley 0 0 0 0 0 0 Walmart Store 7246 Bleckley 0 0 0 0 0 0 Brantley County Health Department Brantley 0 0 2200 3000 0 200 Brooks County Health Dept New Brooks 0 0 3300 4000 0 100 Lee And Pickels Drugs Brooks 0 0 1100 1100 0 0 Lee And Pickels Pharmacy Brooks 0 0 1700 2200 0 0 Primary Care Of Southwest Georgia Quitman Brooks 0 0 300 700 0 0 Seniorpharmcom Llc Brooks 0 0 0 0 0 0 Bedingfield Pharmacy Bryan 0 0 2000 2900 0 0 Bryan County Health Department - Pembroke Bryan 0 0 3600 4100 0 0 Bryan County Health Department - Richmond Hill Bryan 0 0 3900 5200 0 700 Cvs Pharmacy 7783 Bryan 0 0 0 0 0 0 Kroger Pharmacy 688 Bryan 0 0 1300 200 0 0 Publix Pharmacy#1154 Bryan 0 0 2400 1300 0 0 Richmond Hill Pharmacy Bryan 0 0 9100 1900 0 0 Southcoast Health Pediatrics Bryan 0 0 0 0 0 0 Southern Hometown Pharmacy Bryan 0 0 300 200 0 0 Walgreens #10506 Bryan 0 0 800 0 0 0 Applecare Immediate Care Stateboro Bulloch 0 0 0 0 0 0 Bulloch County Health Department Bulloch 0 0 12000 7500 0 300 Provider Name/Clinic Name County Pfizer Doses Requested Total Allocated Pfizer Moderna Doses Requested Total Allocated Moderna Janssen Doses Requested Total Allocated Janssen Bulloch Wellness Center Bulloch 0 0 1000 1300 0 0 East Georgia Regional Medical Center Bulloch 0 0 12800 5600 0 0 Family Health Care Center Bulloch 0 0 8700 600 0 0 Forest Heights Pharmacy Bulloch 0 0 7800 6300 0 1000 Fresenius Medical Care Of
Load more

Recommended publications
  • Snippet Roundup: CETP Kaput and Biogen Buys Into Amyloid
    October 27, 2017 Snippet roundup: CETP kaput and Biogen buys into amyloid Edwin Elmhirst Welcome to your weekly roundup of EP Vantage’s snippets – short takes on smaller news items. This week, October 23 to 27, 2017, we had thoughts on the following: Amgen puts another CETP out of its misery; Stryker buys Vexim without waiting for US approval; How much is aducanumab worth? At least $8bn, Biogen reckons; Alcon delay puts dampener on Novartis; Soliris sitting pretty with complementary new indication; Smith & Nephew acquires, but divestments could follow; Global Blood drops IPF programme. These snippets were previously published daily via twitter. Amgen puts another CETP out of its misery October 26, 2017 If the once-promising CETP drug class lives on, it might only be in a rather restricted group of heart disease patients with a very specific mutation. Amgen became the last big biopharma group to cancel work on a drug in the HDL-raising class when it announced plans to seek a partner for AMG 899, following the lead of Merck & Co, which recently terminated its work with anacetrapib after disappointing results in the Reveal trial. Although big pharma groups obviously believe that it is unlikely for a CETP inhibitor to succeed commercially, it is not out of the realm of possibility that a partner could emerge for AMG 899 – Roche licensed its project, dalcetrapib, to the Canadian group Dalcor Pharmaceuticals, which has been researching its use in a genetic subtype, patients with an AA polymorphism at the rs1967309 location in the ADCY9 gene. Amgen will write off the $300m it paid for AMG 899’s originator, Dezima Pharma, in 2015, which at the time was seen as a cheap bet on the CETP sector.
    [Show full text]
  • Abbvie Allergan Acquisition
    Creating a New Diversified Biopharmaceutical Company The Combination of AbbVie and Allergan Investor Presentation June 25, 2019 NO OFFER OR SOLICITATION This presentation is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction pursuant to the acquisition or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. In particular, this presentation is not an offer of securities for sale into the United States. No offer of securities shall be made in the United States absent registration under the U.S. Securities Act of 1933, as amended, or pursuant to an exemption from, or in a transaction not subject to, such registration requirements. Any securities issued in the acquisition are anticipated to be issued in reliance upon available exemptions from such registration requirements pursuant to Section 3(a)(10) of the U.S. Securities Act of 1933, as amended. The acquisition will be made solely by means of the Scheme Document (or, if applicable, the Takeover Offer document), which will contain the full terms and conditions of the acquisition, including details with respect to the AbbVie shareholder vote in respect of the acquisition. Any decision in respect of, or other response to, the acquisition, should be made only on the basis of the information contained in the Scheme Document. IMPORTANT ADDITIONAL INFORMATION WILL BE FILED WITH THE SEC In connection with the proposed Acquisition, Allergan will file with the Securities Exchange Commission (the “SEC”) a Proxy Statement, which will include the Scheme Document.
    [Show full text]
  • [Docket No. FDA-2017-N-3203] Wyeth Pharmaceutical
    This document is scheduled to be published in the Federal Register on 06/21/2017 and available online at https://federalregister.gov/d/2017-12908, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2017-N-3203] Wyeth Pharmaceuticals Inc. et al.; Withdrawal of Approval of 121 New Drug Applications and 161 Abbreviated New Drug Applications AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is withdrawing approval of 121 new drug applications (NDAs) and 161 abbreviated new drug applications (ANDAs) from multiple applicants. The holders of the applications notified the Agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn. DATES: The withdrawal is effective on [INSERT DATE 30 DAYS AFTER DATE OF PUBLICATION IN THE FEDERAL REGISTER]. FOR FURTHER INFORMATION CONTACT: Florine P. Purdie, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 51, rm. 6248, Silver Spring, MD 20993-0002, 301-796-3601. SUPPLEMENTARY INFORMATION: The holders of the applications listed in table 1 in this document have informed FDA that these drug products are no longer marketed and have requested that FDA withdraw approval of the applications under the process in § 314.150(c) (21 CFR 314.150(c)). The applicants have also, by their requests, waived their opportunity for a hearing. Withdrawal of approval of an application or abbreviated application under § 314.150(c) is without prejudice to refiling. 2 Table 1 Application No.
    [Show full text]
  • Abbott Abbvie ACE Pharmaceuticals Alcon Alfasigma ALK Abello
    Abbott Eisai MSD Animal Health Abbvie Elanco Mundipharma Pharmaceuticals ACE Pharmaceuticals Eli Lilly Mylan Alcon Essity Mylan Healthcare Alfasigma Eurocept Nevro Medical ALK Abello Eurocept Pharmaceuticals Nobel Biocare Allergan EUSA Pharma Nordic Pharma AllweCare Medical Ferring Norgine Pharma Almirall Flen Health Novartis Pharma Amgen FMH Medical Novo Nordisk Amomed Pharma Focus Care Pharmaceuticals Olympus Amryt Pharmaceuticals Fresenius Kabi Otsuka Pharmaceuticals Amryt Research Fresenius Medical Care Paion Apceth Galapagos Biopharma Pentax Arega Medical Galderma Pfizer Arthrex GDM Philips Electronics Astellas Pharma GE Healthcare PIERRE FABRE AstraZeneca Gedeon Richter PIERRE FABRE SANTE AtriCure Genzyme Pro Care AveXis Getinge Recordati B.Braun Medical Gilead Sciences ResMed Bausch&Lomb OPS GlaxoSmithKline Roche Diabetes Care Baxter Goodlife Pharma Roche Diagnostics Bayer Grünenthal Roche Pharma Bayer Animal Health Guerbet Sandoz Becton Dickinson GW Pharma Sanofi Beldico Horus Pharma Sanquin Plasma Products Benu Direct HRA Pharma Santen Biogen IDB Holland Santhera Bio-Rad Laboratories Incyte Biosciences Sarepta Biotronik InSpine Seagen Bioventus Intercept Pharma Seqirus Bluebird Bio Ipsen Farmaceutica Servier Boehringer Ingelheim Janssen -Cilag Shire Boehringer Ingelheim Animal Health Janssen-Cilag (Actelion) Siemens Healthineers Boston Scientific Jazz Pharmaceuticals SkylineDX Bracco Imaging Johnson & Johnson Medical Smith & Nephew Bristol-Myers Squibb Khondrion SoBi (Swedish Orphan Biovitrum) Cablon Medical Kyowa Kirin Pharma
    [Show full text]
  • Sample of Current Attendees
    SAMPLE OF CURRENT ATTENDEES TITLE COMPANY Sr Mgr Global Meetings Mgmt Amgen Prin Tradeshow Spec Boston Scientific Events Mgr PR Medical Events Sr Buyer Pharma Ops ITA Group Travel Services Supv Grifols Asia Pacific Pte Ltd Compliance Specialist GCO Spend Jouney Lead Global Mtgs Travel Events UCB Category Project Specialist Roche Events & Travel Mgr Teva Brasil Mgr Event Mgmt Bayer Congress Mgr MediCongress Services Global Events Mgmt Sr Assoc Amgen Assoc Dir Congresses & Events MSD Internal Event Mgr Gilead Sourcing Mgr BMS Dir Sourcing Meeting Alliance Custoerm Srvs Meetings Mgr Eli Lilly & Company Sr Congress Mgr Novartis Pharmaceuticals Sourcing Mgr BCD Meetings & Events Sr Buyer Meetings & Incentives Worldwide Sourcing Mgr American Express GBT Acct Mgr Venue Sourcing Ashfield Meetings & Events Mtg Planner AbbVie Sr Sourcing Mgr CWT Dir Sourcing Planning Partners International Meetings Mgr ACOG Meeting Mgr Pfizer Canada Global Event Lead Astellas Meeting & Events Sanofi Events Specialist Cook Medical Meetings & Events Mgr Pfizer Spain Pfizer Spain Sr Mgr Hotel Procurement Meetings & Incentives WorldWide Inc Event Planner SFU BCcampus Mgr Global Strategic Mtg Mgmt Teva Pharmaceuticals Global Mtgs & Events Virtual Mtgs Specialist AstraZeneca Global Congress Strategy Lead MSD Assoc Dir Congresses & Events Alnylam Pharmaceuticals Event Planner AbbVie Institutional & Scientific Events Coordr Almirall Congress Mgr AO Spine Sr Meeting Planner Medtronic Mgr Global Mtgs Mgmt Alnylam Pharmaceuticals Meeting Planner AbbVie Global Audit Meetings
    [Show full text]
  • Alcon-20-F-2020.Pdf
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) or 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring the shell company report __________ Commission file number: 001-31269 Alcon Inc. (Exact name of Registrant as specified in its charter) N/A (Translation of Registrant's name into English) Switzerland (Jurisdiction of incorporation or organization) Rue Louis-d'Affry 6, 1701 Fribourg, Switzerland (Address of principal executive office) Royce Bedward, Chemin de Blandonnet 8, 1214 Vernier, Geneva, Switzerland; Tel: +41 58 911 20 00; Fax +41 58 911 32 22 (Name, Telephone, Email and/or Facsimile number and Address of Company Contact Person) Securities registered or to be registered pursuant to Section 12(b) of the Act. Title of each class Trading Symbol(s) Name of each exchange on which registered SIX Swiss Exchange Ordinary Shares, nominal value CHF 0.04 per share ALC New York Stock Exchange Securities registered or to be registered pursuant to Section 12(g) of the Act. None Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act.
    [Show full text]
  • 11/09/2016 Provider Subsystem Healthcare and Family Services Run Time: 20:25:21 Report Id 2794D051 Page: 01
    MEDICAID SYSTEM (MMIS) ILLINOIS DEPARTMENT OF RUN DATE: 11/09/2016 PROVIDER SUBSYSTEM HEALTHCARE AND FAMILY SERVICES RUN TIME: 20:25:21 REPORT ID 2794D051 PAGE: 01 NUMERIC COMPLETE LIST OF PHARMACEUTICAL LABELERS WITH SIGNED REBATE AGREEMENTS IN EFFECT AS OF 01/01/2017 NDC NDC PREFIX LABELER NAME PREFIX LABELER NAME 00002 ELI LILLY AND COMPANY 00145 STIEFEL LABORATORIES, INC, 00003 E.R. SQUIBB & SONS, LLC. 00149 WARNER CHILCOTT PHARMACEUTICALS INC. 00004 HOFFMANN-LA ROCHE 00168 E FOUGERA AND CO. 00006 MERCK & CO., INC. 00169 NOVO NORDISK, INC. 00007 GLAXOSMITHKLINE 00172 IVAX PHARMACEUTICALS, INC. 00008 WYETH LABORATORIES 00173 GLAXOSMITHKLINE 00009 PFIZER, INC 00178 MISSION PHARMACAL COMPANY 00013 PFIZER, INC. 00182 GOLDLINE LABORATORIES, INC. 00015 MEAD JOHNSON AND COMPANY 00185 EON LABS, INC. 00023 ALLERGAN INC 00186 ASTRAZENECA LP 00024 SANOFI-AVENTIS, US LLC 00187 VALEANT PHARMACEUTICALS NORTH AMERICA 00025 PFIZER, INC. 00206 LEDERLE PIPERACILLIN 00026 BAYER HEALTHCARE LLC 00224 KONSYL PHARMACEUTICALS, INC. 00029 GLAXOSMITHKLINE 00225 B. F. ASCHER AND COMPANY, INC. 00032 SOLVAY PHARMACEUTICALS, INC. 00228 ACTAVIS ELIZABETH LLC 00037 MEDA PHARMACEUTICALS, INC. 00245 UPSHER-SMITH LABORATORIES, INC. 00039 SANOFI-AVENTIS, US LLC 00258 FOREST LABORATORIES INC 00046 AYERST LABORATORIES 00259 MERZ PHARMACEUTICALS 00049 PFIZER, INC 00264 B. BRAUN MEDICAL INC. 00051 UNIMED PHARMACEUTICALS, INC 00281 SAVAGE LABORATORIES 00052 ORGANON USA INC. 00299 GALDERMA LABORATORIES, L.P. 00053 CSL BEHRING 00300 TAP PHARMACEUTICALS INC 00054 ROXANE LABORATORIES, INC. 00310 ASTRAZENECA LP 00056 BRISTOL-MYERS SQUIBB PHARMA CO. 00327 GUARDIAN LABS DIV UNITED-GUARDIAN INC 00062 ORTHO MCNEIL PHARMACEUTICALS 00338 BAXTER HEALTHCARE CORPORATION 00064 HEALTHPOINT, LTD. 00378 MYLAN PHARMACEUTICALS, INC.
    [Show full text]
  • 2019 Corporate Responsibility Report
    2019 Corporate Responsibility Report See Brilliantly Our Story About This Report Benefiting Customers Caring for Our Winning in the Working With Integrity ESG Content Indices 2 & Patients Environment Workplace Performance Data Contents A Message From Our CEO 3 Winning in the Workplace 26 Talent Attraction & Retention 27 Our Story 4 Diversity & Inclusion (D&I) 29 Company Overview 5 Health & Safety 31 About This Report 8 Working With Integrity 34 Business Ethics 35 Benefiting Customers Responsible Procurement & 9 37 & Patients Supply Chain Cybersecurity & Data Privacy 39 Medical Innovation 10 Product Quality & Patient Safety 13 ESG Performance Data 41 Access, Affordability & Pricing 15 Philanthropy 17 Content Indices 46 Caring for Our SASB Index 47 20 Environment GRI Index 49 Environmental Sustainability 21 Company Topic-Specific 52 Disclosures Sustainable Products & Services 22 Glossary 53 Reducing Our Environmental 24 Footprint Legal Disclaimers 54 Our Story About This Report Benefiting Customers Caring for Our Winning in the Working With Integrity ESG Content Indices 3 & Patients Environment Workplace Performance Data A Message From Our CEO It is my pleasure to present our first Corporate Responsibility Environment; Winning in the Workplace; and Working with Report as a new public company. We’ve been actively Integrity. We recognize that the road to corporate citizenship engaged in environmental, social, and governance initiatives requires significant reflection and organizational alignment, (ESG) over our 70+ years in ophthalmology and optometry, and it is a journey, not a point in time. While some of our ESG and we are pleased to share with you our perspective on initiatives are more developed, others are still in the early corporate citizenship in this inaugural report.
    [Show full text]
  • Mckesson Corporation
    Annual Report Fiscal Year Ended March 31, 2010 “In fi scal 2010, McKesson continued its track record of delivering outstanding stockholder returns.” John H. Hammergren Chairman, President and Chief Executive Offi cer McKesson Corporation Financial Results *Diluted earnings per share (“EPS”) excludes adjustments for litigation charges (credits), net. For supplemental fi nancial data and corresponding reconciliation to U.S. generally accepted accounting principles (“GAAP”), see Appendix A to this 2010 Annual Report. Non-GAAP measures should be viewed in addition to, and not as an alternative for, fi nancial results prepared in accordance with GAAP. **Assumes $100 invested in McKesson’s common stock and in each index on March 31, 2005, and reinvestment of all dividends. Dear Fellow Stockholders: I am pleased to report that McKesson delivered strong results in fiscal 2010, an achievement made all the more remarkable by the challenging economic environment we faced coming into the year. Rarely in our 177-year history has the Company insurance reimbursement methods. We believe that experienced an era like the present — one that offers our unmatched HIT solution portfolio positions us so many opportunities for success and growth in extremely well to meet these demands. the healthcare industry, while presenting so many questions about the path forward. 3. Deep Customer Relationships An important lesson to be learned from our long With so much change occurring in healthcare, and successful history is that change presents customers are looking for strategic partners who can opportunities, and I can say with confidence that we help them improve their financial, operational, and are well positioned to thrive in the years ahead.
    [Show full text]
  • Annual Report 2019 See Brilliantly See Brilliantly Alcon Is the Global Leader in Eye Care, Dedicated to Helping People See Brilliantly
    Official Sponsor of 20/20 See Brilliantly Annual Report 2019 See Brilliantly See Brilliantly Alcon is the global leader in eye care, dedicated to helping people see brilliantly. With our 70+ year heritage, we are the largest eye care company in the world – with complementary businesses in Surgical and Vision Care. See Brilliantly Being a truly global company, we serve patients in more than 140 countries. We have a long history of industry firsts, and each year we commit a substantial amount in research and development to meet customer needs and patient demands. Table of Contents ii Message from the Board Chair iv Message from the CEO vi Business Summary ix Innovation Milestones x Financial Highlights xiv Alcon’s Strategy xv Corporate Responsibility Message from the Board Chair I am proud of what our team has accomplished following spin-off, Dear Shareholder, Dear Shareholder, particularly in the areas of standing up the new company, accelerating In 1945, two pharmacists in Fort Worth, Texas, Robert our innovation pipeline to grow revenue, and developing the culture to In 1945, two pharmacists in Fort Worth, Texas, Robert Alexander become an agile market leader. Our independence has created Alexander and William Conner, started a company that and William Conner, started a company that would focus tremendous energy among our associates, who can now directly would focus on manufacturing and selling products in a on manufacturing and selling products in a relatively new and participate in our success. In addition, we delivered solid results in relatively new and underserved market at the time: eye care.
    [Show full text]
  • Manufacturers/Wholesalers Street City ST Zip 454 Life Sciences Branford CT A.L.I Holdings, LLC A.L.I
    Manufacturers/Wholesalers Street City ST Zip 454 Life Sciences Branford CT A.L.I Holdings, LLC A.L.I. Imaging Systems Corp A.L.I. Technologies (International) LLC Abbott Diabetes Care Division Abbott Diagnostic Division Abbott Laboratories 100 Abbott Park Rd. Bldg. AP6D-1 Abbott Park IL 60064 Abbott Molecular Division Abbott Nutrition Products Division Abbott Pharmaceutical Products Group Abbott Point of Care Division Abbott Vascular Division Abraxis Bioscience, LLC. 11755 Wilshire Blvd., Suite 2000 Los Angeles CA 90025 Access Diabetic Supply, LLC Acclarent, Inc. 1525-B O'Brien Dr. Menlo Park CA 94025 Acorda Therapeutics, Inc. 15 Skyline Drive Hawthorne NY 10532 Advanced Neuromodulation Systems, Inc. Advanced Respiratory, Inc. Advanced Sterilization Products 33 Technology Drive Irvine CA 92618 Aesculap Implant Systems, Inc. 3773 Corporate Parkway Center Valley PA 18034 Aesculap, Inc. 3773 Corporate Parkway Center Valley PA 18034 Alaven Pharmaceuticals, LLC 2260 Northwest parkway Suite A Marietta GA 30067 Alcon Laboratories, Inc. 6201 South Freeway Fort Worth TX 76134 Alexion Pharmaceuticals, Inc. 352 Knotter Drive Cheshire CT 06410 Alkermes, Inc. 88 Sidney Street Cambridge MA 02139 Allen Medical Systems, Inc. Allergan Sales, LLC Allergan USA, Inc. Allergan, Inc. 2525 Dupont Drive Irvine CA 92612 Alpharma Pharmaceuticals, Inc. Alpharma Pharmaceuticals, LLC AMAG Pharmaceuticals, Inc. 100 Hayden Avenue Lexington MA 02421 AMATECH Corporation American Medical Distributors, Inc. 100 New Highway N Amityville NY 11701 American Medical System,
    [Show full text]
  • Bristol-Myers Squibb 2009 Annual Report
    DELIVERING ON OUR COMMITMENTS 2009 ANNUAL REPORT Bristol-Myers Squibb 345 Park Avenue • New York, NY 10154-0037 This QR-Code can be read with most standard 212-546-4000 • www.bms.com Smartphone QR-Code Reader Apps. ACME-COVER-2009 BMS AR.indd 1 3/8/10 4:59 PM FINANCIAL HIGHLIGHTS Net Sales Dollars in billions ON THE BACK COVER 2009 $18.8 Curtis Horne, a law enforcement officer, was 2008 $17.7 raised on “all the good things that tasted great.” All those “good things” caught up to him one 2007 $15.6 day in 2003 when he collapsed from a heart attack. Now, Curtis takes his medications and Earnings Per Share does everything that his doctor advises. “I eat (from continuing operations attributable to Bristol-Myers Squibb) fruits and vegetables and exercise regularly. GAAP These are the really ‘good things’ that are good for you,” he says. And when he plays with his 2009 $1.63 five grandchildren, he thinks, “I almost wasn’t here for this.” 2008 $1.35 At Bristol-Myers Squibb we believe that the 2007 $0.65 will of the patient, matched by our desire to Non-GAAP find breakthrough medicines, can make all the difference. For more about Curtis and others 2009 $1.85 who are prevailing over serious diseases, visit www.bms.com. 2008 $1.49 2007 $1.04 For further detail on management's use of non-GAAP financial information and reconciliation of non-GAAP to GAAP EPS, see “Management's Discussion and Analysis of Financial Condition and Results of Operations – Non-GAAP Financial Measures” enclosed and the “Quarterly Package of Financial Information” on the company's website at www.bms.com.
    [Show full text]